On Thursday morning the Delhi high court asked the centre to file an affidavit before the
deadline of 3 days twin form about the steps taken to boost the production of amphotericin b
which is an antifungal drug for black fungus. The bench consisted of two judges justice Vipin
sanghi and justice jasmeet Singh who said, “We are afraid that mere doubling of production
may not suffice. It is not clear as to when the augmentation of production could be done
in actual production. The Centre should immediately look into this aspect. A status
report should be filed detailing the present production, the producers, their capacity,
their enhanced capacity and by when can the enhanced capacity be put in use.”“It
appears that the domestic production of the medicine is far less for the requirement on
an all India basis,” they added. They also wanted to help a written document in which
the efforts taken for the import of such medicines from abroad is mentioned.
On behalf of the centre mister kirtiman Singh said that “There are five companies which
are currently producing Amphotericin-B and the shortage is because the demand has
increased due to the increase in demand. Also, the drug is only used in warmer
countries and that too for mosquito bites.” He also assured that the centre has been
taking steps to import the drug from countries which produce it. The issue of shortage of
the drug was raised yesterday in the high court and hence the bench has requested
both the central government and the Delhi government to keep a note on the shortage
of the drug and ensure its earliest availability.
NCB regional director Sameer Wankhede is not targeting Bollywood, his wife Kranti Redkar told India Today on Monday. He also responded to the allegati...
Srinagar: After the recent massacre and the killing of the migrant workers, the J&K Police have coined the term “hybrid”, after lookin...